Profit incentivizes innovation and helps fund research and development.
access to new medicine
Delay or denial of access to life-saving drugs is a potential death sentence.
Innovative new medicines can have a profound impact on the health and wellbeing of those stricken with illness. Unfortunately, Canadians are often denied these benefits for months, if not years, while they wait for their government to approve drugs already deemed safe and effective by regulators in the European Union and United States. Smarter regulation could save resources, reduce patient suffering, and improve the lives of Canadians.